R.PR
REGISTERED-PRINCIPAL REGISTER
26/10/2021
Voltar para busca
Dado oficial do USPTO
CONDUIT TEST
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
CONDUIT TEST
ST13
US500000088960200Classe
5, 9, 42
Pedido
88960200
Registro
6533457
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
21
Atualização mais recente
26/10/2021
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 9, 42
Data de depósito
11/06/2020
Data de registro
26/10/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
26/10/2021
Última transação
26/10/2021
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
99
Localização do titular
BELFAST, GB
Examinador
GUTTADAURO, JULIE
Unidade examinadora
L60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Diaceutics plc
Representantes
MARGARET M. POWERS SHAY GLENN LLP
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Diagnostic testing materials in the nature of reagents for medical use; Medical diagnostic reagents and assays for testing of body fluids; Reagents for use in diagnostic tests for medical purposes
Classe 9
Downloadable computer software for use in relation to medicine and pharmaceutical research and development services for data managementdata analysisdata manipulation; downloadable computer software used to connect laboratory networks and diagnostic and pharmaceutical companies; downloadable computer software used to analyse data in the field of medicine and pharmaceutical testingresearch and development; downloadable computer software for use in relation to business networking and content management in the field of medicine and pharmaceutical testingresearch and development; downloadable computer software applications for data management and visualisationfor generating reportscharts and dashboards in the field of medicine and pharmaceutical research and development
Classe 42
Pharmaceutical drug development services; development of pharmaceutical preparations and medicines; research and development of vaccines and medicines; research relating to medicines; testing of pharmaceuticals; computer aided diagnostic testing servicescomputer-aided diagnostic product testing; design and development of medical diagnostic apparatus; research and development in the field of diagnostic preparations; design and development of computer databases; software design services relating to data processing test tools; provision of information and data relating to medical and veterinary research and development; technical data analysis servicesdata analysis for medicine and pharmaceutical testingresearch and development purposes; informationadvice and consultancy in relation to all the aforesaid servicesproviding information in the field of research and development of pharmaceutical preparations; Software as a service (SAAS) services featuring software in relation to data managementdata analysisdata manipulationmedicine and pharmaceutical testingresearch and development services; Software as a service (SAAS) services featuring software in relation to communication between laboratory networks and diagnostic and pharmaceutical companies; Software as a service (SAAS) services featuring software in relation to data management and visualisationfor generating reportscharts and dashboards; Platform as a service (PAAS) featuring computer software platforms for use in relation to data managementdata analysisdata manipulationmedicine and pharmaceutical testingresearch and development services; Platform as a service (PAAS) featuring computer software platforms for use in relation to communication between laboratory networks and diagnostic and pharmaceutical companies; Platform as a service (PAAS) featuring computer software platforms for use in relation to data management and visualisation for generating reportscharts and dashboards; informationadvice and consultancy in relation to all the aforesaid services
Publicações
Histórico de despachos e eventos da marca no USPTO.
21 publicações encontradas
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/08/2021
PUBO
PUBLISHED FOR OPPOSITION
10/08/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
21/07/2021
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/07/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/07/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/06/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/06/2021
ALIE
ASSIGNED TO LIE
24/06/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/04/2021
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
18/03/2021
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
18/03/2021
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
18/03/2021
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
18/03/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
21/09/2020
GNRT
NON-FINAL ACTION E-MAILED
21/09/2020
CNRT
NON-FINAL ACTION WRITTEN
21/09/2020
DOCK
ASSIGNED TO EXAMINER
14/09/2020
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
05/08/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/07/2020
NWAP
NEW APPLICATION ENTERED
15/06/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CONDUIT TEST ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.